Search
I4 I4 - Immunotherapy of infections using dendritic cells
I4 I4 - Immunotherapy of infections using dendritic cells Issues of future research:Upon delivery with dendritic cells, molecularly defined antigens derived from the protozoan parasite Leishmania…
I1 - Development of novel vaccines against allergies
I1 - Development of novel vaccines against allergies Issues of future research:Since allergic disorders continue to be a major health hazard in the developed countries - 20-30% of the population are…
T5 - RNA transfected dendritic cells as a tumor vaccine
T5 - RNA transfected dendritic cells as a tumor vaccine Issues of future research:The project combines RNA technology and Dendritic Cell biology to fight cancer. The basis of cancerogenesis are…
T4 T4 - Bacteriological Tumortherapy
T4 T4 - Bacteriological Tumortherapy Issues of future research:New strategies will be developed for immunotherapy and the delivery of ProDrug converting enzymes based on bacterial carrier systems.…
T3 - Immuntherapy of tumors by specific tissue ablation
T3 - Immuntherapy of tumors by specific tissue ablation Issues of future research:The standard approach for immunotherapy of tumors is to target the immunsystem against specific tumor antigens.…
T2 T2 - Therapy of solid tumors by adeno-associated virus
T2 T2 - Therapy of solid tumors by adeno-associated virus Research issues:The tumor suppressor p53 is mutated in most the human tumors. The adeno-associated virus type 2 (AAV-2) is able to induce a…
T1 T1 - Identification and Characterization of Target Genes in B Cell Tumors
T1 T1 - Identification and Characterization of Target Genes in B Cell Tumors Issues of future research:The Wnt signal transduction pathway is one of the major forms of cell-cell communication in the…
FORIMMUN
RESEARCH NETWORK FOR NEW STRATEGIES IN IMMUNOTHERAPY
FORGEN I GV9 Untersuchungen zur Persistenz und Mobilität gentherapeutischer Vektoren an einem System zur Apoptoseinduktion bei onkologischen und rheumatologischen Erkrankungen
FORGEN I GV9 Untersuchungen zur Persistenz und Mobilität gentherapeutischer Vektoren an einem System zur Apoptoseinduktion bei onkologischen und rheumatologischen Erkrankungen
FORGEN I GV8 Verbesserung retroviraler Vektoren durch Einsatz von Foamyviren
FORGEN I GV8 Verbesserung retroviraler Vektoren durch Einsatz von Foamyviren